期刊文献+

rt-PA静脉溶栓治疗急性脑梗死的研究 被引量:2

Study of rt-PA intravenous thrombolysis on acute cerebral infarction
暂未订购
导出
摘要 目的观察重组组织型纤溶酶原激活剂(rt—PA)静脉溶栓治疗早期急性脑梗死的疗效和安全性。方法将75例急性脑梗死(发病时间〈3h)患者随机分为2组:溶栓组40例用rt—PA0.9mg/kg,先于2min内静脉注射总量中的10%,再将余量于1h内静脉泵入;对照组35例不使用rt—PA。2组其他治疗均相同。观察治疗前及治疗后6h、24h、7d、30d、90d的临床神经功能缺损程度评分(CSS),治疗前、治疗后90d日常生活活动量表(Barthel指数),30d脑出血率、病死率。结果溶栓组溶栓后6h、24h、7d、30d、90dCSS为15.38,13.24,9.30,7.40,5.00分;90d总显效率为76%;90dBarthd指数评分为95~100分者占57%;脑出血率为10%;病死率为5%。对照组治疗后6h、24h、7d、30d、90dCSS为20.65,18.78,14.90,13.00,11,95分;90d总显效率为30%;90dBarthel指数评分为95~100分者占22%;无颅内出血;病死率为9%。溶栓组CSS明显低于对照组(P〈0.01),总显效率明显高于对照组(P〈0.01)。结论急性脑梗死早期应用rt—PA静脉溶栓是安全有效的。 Objective It is to observe the efficacy and safety of recombinant tissue plasminogen activator (rt- PA) intravenous thrombolysis on patients with early acute cerebral infarction. Methods 75 cases of acute cerebral infarction within 3 hours from the onset of stroke were randomly divided into two groups: intravenous thrombolysis group (40 cases) and control group (35 cases), rt- PA was administrated in a dose of 0.9mg/kg, 10% of total dose was injected intravenously in 2 minutes, and the rest was infused in 1 hour for intravenous thrombolysis group. The control group received only routine treatment. Scoring Clinical Stroke Scale (C.SS) before treatment, in 24 hours, 7 days, 30 days and 90 days after treatment, Barthel index (BI), mortality and side effects before treatment and 90days after treatment were all observed. Results Scoring of C.SS 6 hours, 24 hours 7 days, 30 days and 90 days after treatment were 15.38, 13.24, 9.30, 7.40, 5.00 in intra- venous thrombolysis group, and 20.65, 18.78, 14.90, 13.00, 11.95 in control group. High score of BI ( 95 -- 100) at 90 days after treatment were 57 % in intravenous thrombolysis group and 22 % in control group. The efficacy rate and mortality rate were 76 %, 5 % in intravenous thrombolysis group, and 30 % , 9 % in control group. All the data showed there were significant differences in CSS and total effective rate between the two groups (P〈 0.01 ). Conclusion Early application of rt- PA intravenous thrombolysis is effective and safe for patients with acute cerebral infarction.
出处 《现代中西医结合杂志》 CAS 2008年第4期494-496,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 重组组织型纤溶酶原激活剂 静脉溶栓 急性脑梗死 rt- PA intravenous thrombolysis acute cerebral infarction
  • 相关文献

参考文献7

  • 1Zivin JA. Factors determining the therapeutic window for stroke [J]. Neurology, 1998,50(3) :599 - 603
  • 2Fieschi C,Argention C, Lenai GL, et al. Clinical and instrumental evaluation on patients with ischemic stoke within the first six hours [J]. J Neurol Sic,1989,91(2) :311 - 321
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15807
  • 4Hacke W,Kaste M,Fieschi C,et al. For the ECASS study group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the european cooperative acute stroke study (ECASS) [J]. Jama, 1995,274(13) : 1017 - 1025
  • 5The National institute of neurological disorde rsand stroke rt - PA study group. Tissue plasmlnogen activator for acute ischemic stroke [J]. N Engl Med,1995,333(24):1581- 1587
  • 6国家'九五'攻关课题协作组.急性脑梗死(6h以内)静脉溶栓治疗[J].中风与神经疾病杂志,2001,18(5):259-261. 被引量:155
  • 7刘士民,郭玉璞.脑缺血半暗带的研究进展[J].中华神经科杂志,1996,29(6):365-367. 被引量:36

二级参考文献9

  • 1[1]Hantson L,Deweerdt W,De keyser J,et al. The European Stroke Scale[J]. Stroke,1994,25:2215-2219.
  • 2[2]Memezawa H,Simith ML,Siesjo BK. Penumbral tissue salvaged by reperfusion following middle cerebral artery occlusion in rats[J]. Stroke,1992,23:552-567.
  • 3[3]Del Zoppo GJ,Pessin MS,Mori E,et al. Thrombolytic intervention in acute thrombolic and embolic stroke[J]. Semin Neurol,1991,11:368-384.
  • 4[4]The ECASS Study Grroup. Intravenous thrombolysis with recombinant tissue plasminogcn activator for acute hemispheric stroke[J]. JAMA,1995,274:1017-1025.
  • 5[5]The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med,1995,333:1581-1592.
  • 6[6]Multicenter Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase,aspirin and combination of both in treatment of acute ischemic stroke[J]. Lancet,1995,346:1509-1514.
  • 7Li Y,J Neurol Sci,1995年,128卷,134页
  • 8Zhang R L,Neurology,1994年,44卷,1747页
  • 9Chen H,J Neurol Sci,1993年,118卷,109页

共引文献15959

同被引文献15

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部